Meta-analysis of quantitative diffusion-weighted MR imaging in differentiating benign and malignant pancreatic masses

Xiang-ke Niu , Anup Bhetuwal , Sushant Das , Ying-quan Xiao , Feng Sun , Li-chuan Zeng , Han-feng Yang

Current Medical Science ›› 2014, Vol. 34 ›› Issue (6) : 950 -956.

PDF
Current Medical Science ›› 2014, Vol. 34 ›› Issue (6) : 950 -956. DOI: 10.1007/s11596-014-1379-9
Article

Meta-analysis of quantitative diffusion-weighted MR imaging in differentiating benign and malignant pancreatic masses

Author information +
History +
PDF

Abstract

There have been numerous studies done to explore the diagnostic performance of quantitative diffusion-weighted (DW) MR imaging to differentiate between benign and malignant pancreatic masses. However, the results have been inconsistent. We performed a meta-analysis to investigate whether DW-MR imaging can differentiate between these two diseases. Databases including MEDLINE, EMBASE and Cochrane Library were utilized to find relevant articles published between January 2001 and January 2014. A Stata version 12.0 and a Meta-Disc version 1.4 were used to describe primary results. Twelve studies with 594 patients, which fulfilled the inclusion criteria, were enrolled for the analysis. The pooled sensitivity and specificity of DW imaging was 0.91 (95% CI: 0.84, 0.95) and 0.86 (95% CI: 0.76, 0.93) respectively. The area under the curve of the summary receiver operating characteristic was 0.95 (95% CI: 0.93, 0.96). The results indicated that DW imaging might be a valuable tool for differentiating benign and malignant pancreatic masses.

Keywords

apparent diffusion coefficient / diffusion-weighted imaging / magnetic resonance imaging / meta-analysis / pancreatic tumor / pancreatic adenocarcinoma

Cite this article

Download citation ▾
Xiang-ke Niu, Anup Bhetuwal, Sushant Das, Ying-quan Xiao, Feng Sun, Li-chuan Zeng, Han-feng Yang. Meta-analysis of quantitative diffusion-weighted MR imaging in differentiating benign and malignant pancreatic masses. Current Medical Science, 2014, 34(6): 950-956 DOI:10.1007/s11596-014-1379-9

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

NanashimaA, TobinagaS, AboT, et al. . Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute. Hepatogastroenterology, 2012, 59(115): 911-915 PMID: 22469741

[2]

LiD, XieK, WolffR, et al. . Pancreatic cancer. Lancet, 2004, 363(9414): 1049-1057 PMID: 15051286

[3]

PadhaniAR, LiuG, KohDM, et al. . Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia, 2009, 11(2): 102-125 PMCID: 2631136 PMID: 19186405

[4]

BruegelM, HolzapfelK, GaaJ, et al. . Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol, 2008, 18(3): 477-485 PMID: 17960390

[5]

GourtsoyianniS, PapanikolaouN, YarmenitisS, et al. . Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focalliver lesions. Eur Radiol, 2008, 18(3): 486-492 PMID: 17994317

[6]

KangKM, LeeJM, YoonJH, et al. . Intravoxel incoherent motion diffusion-weighted MR imaging for characterization of focal pancreatic lesions. Radiology, 2014, 270(2): 444-453 PMID: 24126370

[7]

MoherD, LiberatiA, TetzlaffJ, et al. . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg, 2010, 8(5): 336-341 PMID: 20171303

[8]

LiberatiA, AltmanDG, TetzlaffJ, et al. . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol, 2009, 62(10): e1-e34 PMID: 19631507

[9]

WhitingP, RutjesAW, ReitsmaJB, et al. . The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol, 2003, 3: 25 PMCID: 305345 PMID: 14606960

[10]

Huedo-MedinaTB, Sánchez-MecaJ, Marín-MartínezF, et al. . Assessing heterogeneity in meta-analysis: Q statistic or I 2 index?. Psychol Methods, 2006, 11(2): 193-206 PMID: 16784338

[11]

LeeflangMM, DeeksJJ, GatsonisC, et al. . Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of diagnostic test accuracy. Ann Intern Med, 2008, 149(12): 889-897 PMCID: 2956514 PMID: 19075208

[12]

SongF, KhanKS, DinnesJ, et al. . Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol, 2002, 31(1): 88-95 PMID: 11914301

[13]

ZamoraJ, AbrairaV, MurielA, et al. . Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol, 2006, 6: 31 PMCID: 1552081 PMID: 16836745

[14]

MosesLE, ShapiroD, LittenbergB. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med, 1993, 12(14): 1293-1316 PMID: 8210827

[15]

KartalisN, LindholmTL, AspelinP, et al. . Diffusion-weighted magnetic resonance imaging of pancreas tumours. Eur Radiol, 2009, 19(8): 1981-1990 PMID: 19308414

[16]

ConciaM, SprinkartAM, PennerAH, et al. . Diffusion-weighted magnetic resonance imaging of the pancreas: diagnostic benefit from an intravoxel incoherent motion model-based 3 b-value analysis. Invest Radiol, 2014, 49(2): 93-100 PMID: 24089021

[17]

IchikawaT, ErturkSM, MotosugiU, et al. . High-b value diffusion-weighted MRI for detecting pancreatic adenocarcinoma: preliminary results. AJR Am J Roentgenol, 2007, 188(2): 409-414 PMID: 17242249

[18]

HurBY, LeeJM, LeeJE, et al. . Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma. J Magn Reson Imaging, 2012, 36(1): 188-197 PMID: 22371378

[19]

MuhiA, IchikawaT, MotosugiU, et al. . Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangio-pancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging, 2012, 35(4): 827-836 PMID: 22069025

[20]

HuangWC, ShengJ, ChenSY, et al. . Differentiation between pancreatic carcinoma and mass-forming chronic pancreatitis: usefulness of high b value diffusion-weighted imaging. J Dig Dis, 2011, 12(5): 401-408 PMID: 21955434

[21]

LeeSS, ByunJH, ParkBJ, et al. . Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses. J Magn Reson Imaging, 2008, 28(4): 928-936 PMID: 18821618

[22]

KlaussM, LemkeA, GrünbergK, et al. . Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Invest Radiol, 2011, 46(1): 57-63 PMID: 21139505

[23]

KamisawaT, TakumaK, AnjikiH, et al. . Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI. Am J Gastroenterol, 2010, 105(8): 1870-1875 PMID: 20216538

[24]

SandrasegaranK, AkisikFM, PatelAA, et al. . Diffusion-weighted imaging in characterization of cystic pancreatic lesions. Clin Radiol, 2011, 66(9): 808-814 PMID: 21601184

[25]

FatimaZ, IchikawaT, MotosugiU, et al. . Magnetic resonance diffusion-weighted imaging in the characterization of pancreatic mucinous cysticlesions. Clin Radiol, 2011, 66(4): 108-111 PMID: 21216325

[26]

SchraibmanV, GoldmanSM, ArdenghJC, et al. . New trends in diffusion-weighted magnetic resonance imaging as a tool in differentiation of serous-cystadenoma and mucinous cystic tumor: a prospective study. Pancreatology, 2011, 11(1): 43-51 PMID: 21412024

[27]

JonesCM, AthanasiouT. Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg, 2005, 79(1): 16-20 PMID: 15620907

[28]

FletcherJG, WiersemaMJ, FarrellMA, et al. . Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detectorrow CT. Radiology, 2003, 229(1): 81-90 PMID: 14519871

[29]

FarmaJM, SantillanAA, MelisM, et al. . PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms. Ann Surg Oncol, 2008, 15(9): 2465-2471 PMID: 18551347

[30]

AgarwalB, Abu-HamdaE, MolkeKL, et al. . Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis ofpancreatic cancer. Am J Gastroenterol, 2004, 99(5): 844-850 PMID: 15128348

[31]

RothY, TichlerT, KostenichG, et al. . High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumorresponse to therapy in mice. Radiology, 2004, 232(3): 685-692 PMID: 15215551

[32]

WuLM, XuJR, HuaJ, et al. . Value of diffusion-weighted imaging for the discrimination of pancreatic lesions: a meta-analysis. Eur J Gastroenterol Hepatol, 2012, 24(2): 134-142 PMID: 22241215

[33]

InanN, ArslanA, AkanselG, et al. . Diffusion-weighted imaging in the differential diagnosis of cystic lesions of the pancreas. AJR Am J Roentgenol, 2008, 191(4): 1115-1121 PMID: 18806153

[34]

TajimaY, KurokiT, TsutsumiR, et al. . Pancreatic carcinoma coexisting with chronic pancreatitis versus tumor-forming pancreatitis:diagnostic utility of the time-signal intensity curve from dynamic contrast-enhanced MR imaging. World J Gastroenterol, 2007, 13(6): 858-865 PMCID: 4065920 PMID: 17352014

AI Summary AI Mindmap
PDF

106

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/